Cadila Healthcare Fact Sheet, Cadila Healthcare Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cadila Healthcare Fact Sheet    (CADIL)


Discover Now: One Stock for Potentially Life-changing Gains


Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price Rs 603.1
Mkt Cap Rs m 617,418
Vol '000 596.0
P/E X 33.9
P/CF X 33.0
EPS (TTM) Rs 17.8
% ch % 0.2
No. of shares m 1,023.74
% ch week % 7.4
% ch 1-mth % 32.0
% ch 12-mth % 84.6
52 week H/L Rs 611.5/318.1
(As on May 7, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
CADILA HEALTHCARE EQUITY SHARE DATA
High Rs454460558432352 
Low Rs305305362306207 
Sales per share (Unadj.) Rs92.191.6116.3128.6139.2 
Earnings per share (Unadj.) Rs19.214.817.918.511.8 
Diluted earnings per shareRs19.214.817.918.511.8 
Cash flow per share (Unadj.) Rs22.018.523.124.418.6 
Dividends per share (Unadj.) Rs3.203.203.503.503.50 
Adj. dividends per shareRs3.203.203.503.503.50 
Dividend yield (eoy) %0.80.80.80.91.3 
Book value per share (Unadj.) Rs55.768.085.4101.5101.4 
Adj. book value per shareRs55.768.085.4101.5101.4 
Shares outstanding (eoy) m1,023.741,023.741,023.741,023.741,023.74 
Bonus/Rights/Conversions  FV5:1---- 
Price / Sales ratio x4.14.24.02.92.0 
Avg P/E ratio x19.825.825.719.923.7 
P/CF ratio (eoy) x17.220.719.915.115.0 
Price / Book Value ratio x6.85.65.43.62.8 
Dividend payout %16.721.619.618.929.8 
Avg Mkt Cap Rs m388,458391,581470,664378,170286,033 
No. of employees `00015.416.911.812.413.4 
Total wages/salary Rs m12,61615,19818,54521,24124,145 
Avg. sales/employee Rs Th6,105.05,563.010,072.710,585.010,632.7 
Avg. wages/employee Rs Th817.0901.71,569.11,707.81,801.2 
Avg. net profit/employee Rs Th1,272.1901.51,547.71,526.5898.5 
CADILA HEALTHCARE INCOME DATA
Net Sales Rs m94,26893,765119,049131,656142,531 
Other income Rs m1,1561,2841,1322,0111,139 
Total revenues Rs m95,42495,049120,181133,667143,670 
Gross profit Rs m23,30519,04428,47529,73124,198 
Depreciation Rs m2,9213,7335,3885,9866,965 
Interest Rs m5284469111,9353,418 
Profit before tax Rs m21,01216,14923,30823,82114,954 
Minority Interest Rs m430338628469288 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-25-3000 
Tax Rs m1,7741,2895,6445,3033,198 
Profit after tax Rs m19,64315,19518,29218,98712,044 
Gross profit margin %24.720.323.922.617.0 
Effective tax rate %8.48.024.222.321.4 
Net profit margin %20.816.215.414.48.5 
CADILA HEALTHCARE BALANCE SHEET DATA
Current assets Rs m42,80460,22382,00584,98187,154 
Current liabilities Rs m34,61053,05860,72073,42582,694 
Net working cap to sales %8.77.617.98.83.1 
Current ratio x1.21.11.41.21.1 
Inventory Days Days5270737571 
Debtors Days Days68899811094 
Net fixed assets Rs m46,98772,98483,703133,493133,236 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m55,96868,57686,421102,839102,733 
Net worth Rs m56,99269,60087,445103,863103,757 
Long term debt Rs m8,96424,68425,55139,49732,146 
Total assets Rs m105,506152,207180,653234,831236,866 
Interest coverage x40.837.226.613.35.4 
Debt to equity ratio x0.20.40.30.40.3 
Sales to assets ratio x0.90.60.70.60.6 
Return on assets %19.110.310.68.96.5 
Return on equity %34.521.820.918.311.6 
Return on capital %33.318.022.018.313.7 
Exports to sales %47.20000 
Imports to sales %6.20000 
Exports (fob) Rs m44,5370000 
Imports (cif) Rs m5,8380000 
Fx inflow Rs m44,88121,28042,68348,40452,752 
Fx outflow Rs m9,06910,87411,24211,59314,504 
Net fx Rs m35,81210,40631,44136,81138,248 
CADILA HEALTHCARE CASH FLOW
From Operations Rs m 18,935 13,117 9,193 12,819 25,054 
From Investments Rs m -8,635 -28,719 -9,737 -42,387 -10,123 
From Financial Activity Rs m -9,348 23,158 515 18,846 -10,942 
Net Cashflow Rs m 991 7,556 -29 -8,109 3,989 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 8.3%
FIIs 5.9%
ADR/GDR 0.0%
Free float 11.0%
Shareholders 44,069
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
E-MAIL upen.shah@zyduscadila.com WEB www.zyduscadila.com
TELEPHONE (079) 2686 8326 FAX (079) 2686 2365
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
AUDITOR Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 0.6

Read: CADILA HEALTHCARE 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   BIOCON   ALKEM LABORATORIES  TORRENT PHARMA  ELDER PHARMA  ALEMBIC PHARMA  

Compare CADILA HEALTHCARE With:   BIOCON   ALKEM LABORATORIES  TORRENT PHARMA  ELDER PHARMA  ALEMBIC PHARMA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - MYLAN COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS